SPOKE LEADER
- University of Florence (UNIFI)
Affiliated Partners
- University of Pisa (UNIPI)
- University of Siena (UNISI)
- National Research Council (CNR)
- University for Foreigners of Siena (UNISTRASI)
- Tuscany Life Sciences Foundation (TLS)
- Digital Innovation HUB Tuscany (DIH)
Spoke 5 is the driving force that transforms research into tangible value for the health ecosystem. It involves defining strategies and intellectual property management for the transfer of technological innovations, including the dissemination of results, the formation of new competencies, and the fostering of network activities with partners and stakeholders. This spoke also supports startups by providing financial backing for developing and implementing innovative solutions at the operational level.
Innovation is not just a concept: with Spoke 5, research aims to achieve real-world impact., research finds its real impact.
Clinical research, health data, and biobanks – Guidance documents developed by Spoke 5 now available
Healthcare data are now at the forefront of innovation in the health sector, but their management and use require particular attention for ethical, privacy, regulatory, and technical reasons in their processing, from the moment they are produced or provided. As part of the activities of Spoke 5, an analysis of these issues was therefore carried out as a tool to frame the reference context, enriched by the contribution of experts who explored specific aspects related to the accreditation of biobanks, the problem of monetizing biological samples, data sharing, and the impact of digitalization on clinical research.
Two guidance documents were subsequently developed and made available: one concerning the reality of biobanks (https://doi.org/10.5281/zenodo.17598346) and the second on the use of health data for research purposes (https://tinyurl.com/mjzzhha6).
Although the context in which these issues arise is continuously and rapidly evolving, the documents presented aim to provide an overall perspective for those approaching these important tools of clinical research for the first time.
